GPX4 has been shown to be associated with cardiovascular diseases, whereby overexpression of GPX4 in apolipoprotein E-deficient mice and in a myocardial ischemia/reperfusion mouse model inhibits the development of atherosclerosis and protects cardiac contractile function, respectively [10, 11]. Here, GPX4 is linked to cardiovascular disorder.